{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:04:38Z","timestamp":1761609878612},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2080,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1463-1318.2009.02164.x","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T02:21:31Z","timestamp":1261448491000},"page":"617-626","source":"Crossref","is-referenced-by-count":12,"title":["A meta-analysis of randomized controlled trials comparing antibacterial therapy with placebo in Crohn\u2019s disease"],"prefix":"10.1111","volume":"13","author":[{"given":"J.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,21]]},"reference":[{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.suc.2007.03.014","article-title":"Current medical therapy for chronic inflammatory bowel diseases","volume":"87","author":"Tamboli","year":"2007","journal-title":"Surg Clin North Am"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00005176-200007000-00003","article-title":"Enteral nutrition: the neglected primary therapy of active Crohn\u2019s disease","volume":"31","author":"Griffiths","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.0105-2896.2005.00293.x","article-title":"Defects in mucosal immunity leading to Crohn\u2019s disease","volume":"206","author":"Cobrin","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/path.2291","article-title":"Innate immunity in inflammatory bowel disease: a disease hypothesis","volume":"214","author":"Marks","year":"2008","journal-title":"J Pathol"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.clinthera.2006.12.012","article-title":"A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn\u2019s disease","volume":"28","author":"Rahimi","year":"2006","journal-title":"Clin Ther"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(78)92699-5","article-title":"Myco-bacteria as a possible cause of inflammatory bowel disease","volume":"2","author":"Burnham","year":"1978","journal-title":"Lancet"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/gut.33.7.890","article-title":"Mycobacterium paratuberculosis DNA in Crohn\u2019s disease tissue","volume":"33","author":"Sanderson","year":"1992","journal-title":"Gut"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1572-0241.2000.01842.x","article-title":"A meta-analysis of antimycobacterial therapy for Crohn\u2019s disease","volume":"95","author":"Borgaonkar","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB10|cit10","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008] 2008","DOI":"10.1002\/9780470712184"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB11|cit11","volume-title":"Methods for Meta-Analysis in Medical Research","author":"Sutton","year":"2000"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Di"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/00365527809179816","article-title":"Metronidazole in Crohn\u2019s disease. A double blind cross-over clinical trial","volume":"13","author":"Blichfeldt","year":"1978","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02552649","article-title":"Antibiotic therapy for treatment in relapse of intestinal Crohn\u2019s disease. A prospective randomized study","volume":"28","author":"Ambrose","year":"1985","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/gut.32.9.1071","article-title":"Double blind, placebo controlled trial of metronidazole in Crohn disease","volume":"32","author":"Sutherland","year":"1991","journal-title":"Gut"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00054725-200201000-00002","article-title":"Preliminary study of ciprofloxacin in active Crohn\u2019s disease","volume":"8","author":"Arnold","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","article-title":"Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn\u2019s disease with infliximab: a double-blind placebo-controlled study","volume":"20","author":"West","year":"2004","journal-title":"Aliment Pkarmacol Tker"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2036.2006.02879.x","article-title":"Antibiotic treatment of Crohn\u2019s disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin","volume":"23","author":"Prantera","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1365-2036.2008.03661.x","article-title":"Clinical trial: randomized study of clarithromycin versus placebo in active Crohn\u2019s disease","volume":"27","author":"Leiper","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000198703","article-title":"Sulphadoxine-pyrimethamine therapy in Crohn\u2019s disease","volume":"23","author":"Elliott","year":"1982","journal-title":"Digestion"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/gut.25.2.203","article-title":"Controlled trial of rifampicin and ethambutol in Crohn\u2019s disease","volume":"25","author":"Shaffer","year":"1984","journal-title":"Gut"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB24|cit24","first-page":"245","article-title":"Controlled trial of rifabutin in Crohn\u2019s disease","volume":"46","author":"Basilisco","year":"1989","journal-title":"Curr Ther Res"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/gut.35.3.363","article-title":"Controlled trial of anti-tuberculous chemotherapy for two years in Crohn\u2019s disease","volume":"35","author":"Swift","year":"1994","journal-title":"Gut"},{"key":"10.1111\/j.1463-1318.2009.02164.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2007.03.031","article-title":"Two-Year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn\u2019s disease","volume":"132","author":"Selby","year":"2007","journal-title":"Gastroenterology"}],"container-title":["Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1318.2009.02164.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1463-1318.2009.02164.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T03:56:38Z","timestamp":1625543798000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1463-1318.2009.02164.x"}},"subtitle":["Antibacterial therapy for Crohn\u2019s disease"],"short-title":[],"issued":{"date-parts":[[2009,12,21]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1463-1318.2009.02164.x","relation":{},"ISSN":["1462-8910"],"issn-type":[{"value":"1462-8910","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,21]]}}}